Admission Date:  [**2180-5-24**]              Discharge Date:   [**2180-5-30**]  Date of Birth:  [**2128-3-3**]             Sex:   M  Service: MEDICINE  Allergies: Patient recorded as having No Known Allergies to Drugs  Attending:[**First Name3 (LF) 5552**] Chief Complaint: Hemetemesis   Major Surgical or Invasive Procedure: EGD on [**5-24**] with esophageal banding   History of Present Illness: 52 yo M with pancreatic cancer s/p XRT and several rounds of CTX without response, recently started Taxol, history of esophagitis and GIB at GE junction in [**3-/2180**], presented last night to the ED with coffee ground emesis.
He was lavaged and this procedure produced 800cc of brown guaiac positive contents.
He then had an episode of hemetemesis ([**12-6**] cups).
He was transfused 2 units with no increase in hct, so was therefore given an additional 2 units.
Hypertension Hypercholesterolemia Rhinoplasty R knee arthroplasty  ONC hx: Initially developed lower back pain fall [**2177**] and acute onset of epigastric pain after PO intake in [**11-6**].
Had ultrasound to look for biliary disease; unrevealing.
Treated first with XRT and gemcitabine; tolerated treatment well except for some thrombocytopenia.
Was then placed on protocol for pancreatic CA with capecitabine (Xeloda) and oxaliplatin.
Had some shrinkage of primary pancreatic mass on this protocol but experienced paresthesias, development of intention tremor, and peeling of skin over feet.
He experienced persistent neuropathy but continued on protocol at adjusted doses given stability of disease.
Started on docetaxel (taxotere) c neulasta injections [**2180-3-15**].
Neuropathy secondary to chemotherapy   Social History: The patient worked as a dentist, is married with 3 children and has a 15 pack year tob history.
A focal nodule within the right liver lobe adjacent to the gallbladder measures 5.9 x 5.0 x 5.8 cm, and corresponds with a nodule seen on prior CT which measured 3.2 x 3.1 cm.
[**5-29**] paracentesis:PROCEDURE:  Pre-procedure written informed consent and pre-procedure timeout confirming the patient identity and site and nature of procedure to be performed was obtained.
3.3 liters of clear straw-colored fluid was aspirated for therapeutic purposes.
IMPRESSION:  Successful therapeutic paracentesis, with drainage of 3.3 liters of straw-colored ascites with no immediate complications.
Given the varices found on EGD he was started on an octreotide drip.
On the oncology floor the patient was treated with a PPI IV BID and carafate.
The patient was started on levofloxacin for SBP prophylaxis.
Nadolol treatment was initiated when the five days of octreotide treatment where fininished.
Upon discharge the patient was tolerating PO and hemodynamically stable.
The patient had a therapuetic paracentesis for relief of his discomfort.
Hypertension: The patients BP was monitored and he was given Lisinopril to keep SBP<140 in an attempt to prevent a rebleed.
Medications on Admission: Protonix 40 mg QD Reglan 10 mg QID Compazine 10 mg QID Neurontin 300 mg QD   Discharge Medications: 1.
Gabapentin 300 mg Tablet Sig: One (1) Tablet PO HS (at bedtime).
Nadolol 20 mg Tablet Sig: 0.5 Tablet PO DAILY (Daily).
Lisinopril 5 mg Tablet Sig: One (1) Tablet PO once a day.
Metoclopramide 10 mg Tablet Sig: One (1) Tablet PO QID (4 times a day) as needed.
Sucralfate 1 g Tablet Sig: One (1) Tablet PO QID (4 times a day).
Levofloxacin 500 mg Tablet Sig: One (1) Tablet PO Q24H (every 24 hours).
Trazodone 50 mg Tablet Sig: 0.5 Tablet PO at bedtime as needed for insomnia.
Senna 8.6 mg Tablet Sig: One (1) Tablet PO BID (2 times a day) as needed.
Bisacodyl 10 mg Suppository Sig: One (1) Suppository Rectal HS (at bedtime) as needed.
Docusate Sodium 100 mg Capsule Sig: Two (2) Capsule PO BID (2 times a day) as needed for constipation.
Pantoprazole 40 mg Recon Soln Sig: One (1) Recon Soln Intravenous  Q12H (every 12 hours).
Please take all medications as directed.
